Advanced Search

Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1999 July-August;65(7-8) > Minerva Anestesiologica 1999 July-August;65(7-8):541-8

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036

 

Minerva Anestesiologica 1999 July-August;65(7-8):541-8

ANTALGIC THERAPY 

 REVIEWS

Herpes Zoster and post-herpetic neuralgia: everything to revise?

Pasqualucci A.

Università degli Studi - Udine, Cattedra di Anestesiologia e Rianimazione, Policlinico Universitario

The treatment and prevention of the algic symptomatology of Post-Herpetic Neuralgia (PHN) are problems still to be solved. In our opinion the reason of this failure is to be found in an insufficient knowledge of the pathophysiological phenomena which cause the PHN. In fact, many fundamental aspects, such as its “temporal” and symptomatological definition and its pathogenesis are still unsolved. This revision tries to focus the problems and discrepancies hindering an improvement in PHN treatment and prevention. The literature reports three different symptomatological levels after herpes zoster acute phase: patients affected by pain and/or allodynia, patients with “abnormal sensations” (anesthesia, paresthesia, dysesthesia, prickling, itching, burning, etc.,) and patients in “complete recovery”. Only two studies have analyzed the final incidence of these symptomatologies. Therefore, it is absolutely unclear whether the patients in “abnormal sensations”, that is with a symptomatology which is definitely less weakening than pain, have to be considered in PHN (patients with pain) or in “complete recovery”. On the contrary, from a clinical and physiopathological point of view this symptomatological difference may have a great importance:
— the symptomatological non-distinction could be the cause of the disagreement concerning PHN incidence data;
— this distinction could differentiate and compare in a reliable way the effects of the various therapies reported in the literature.
The lack of a symptomatological classification does not facilitate a verification of the physiopathological hypothesis of PHN onset and maintenance. The differentiation among pain, “abnormal sensations” and “complete recovery” could correlate these three symptomatological conditions to the anatomopathological and viral data which according to literature characterize the evolution of Herpes Zoster acute phase in PHN. This would largely help to improve the therapeutic strategy.

language: Italian


FULL TEXT  REPRINTS

top of page